Clinical Trials Directory

Trials / Completed

CompletedNCT03157583

A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations

Determination of the Sun Protection Factor (SPF) and in Vitro UVA Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the SPF and UVAPF of four sunscreen formulations using international standard methodologies ISO24444:2010 for SPF and ISO24443:2012 for UVAPF.

Detailed description

This study consist of two steps. Step 1: determination of the SPF of the test products which will be performed as a single-center, randomized, evaluator blind, intra-individual comparison, no treatment and positive controlled clinical study as per ISO24444:2010. And Step 2: determination of the UVAPF of the test products which will be performed as a single center, open-label, negative and positive controlled technical test as per ISO24443:2012 (using test plates for assessing UV transmittance of four developmental sunscreens).

Conditions

Interventions

TypeNameDescription
OTHERNGBUV000A, (Expected SPF 30)A total of 2.0 ± 0.05 mg/cm2 (milligram per centimeter square of test site area) NGBUV000A (test product 1) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 1 will be applied to the test plates.
OTHERNGBUV000B, (Expected SPF 30)A total of 2.0 ± 0.05 mg/cm2 NGBUV000B (test product 2) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 2 will be applied to the test plates.
OTHERNGBUV000C, (Expected SPF 30)A total of 2.0 ± 0.05 mg/cm2 NGBUV000C (test product 3) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 3 will be applied to the test plates.
OTHERNGBUV000D, (Expected SPF 30)A total of 2.0 ± 0.05 mg/cm2 NGBUV000D (test product 4) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 4 will be applied to the test plates.
OTHERP3 Standard, (Expected SPF 16)A total of 2.0 ± 0.05 mg/cm2 reference P3 standard will be spread at the topical test sites on the back of each participant.
OTHERSunscreen formulation S2A total of 1.3 mg/cm2 of sunscreen formulation S2 will be applied to the test plates.
OTHERGlycerinA total of 1.3 mg/cm2 of glycerin will be applied to the test plates.

Timeline

Start date
2017-06-21
Primary completion
2017-07-07
Completion
2017-07-07
First posted
2017-05-17
Last updated
2019-07-22
Results posted
2019-07-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03157583. Inclusion in this directory is not an endorsement.

A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sun (NCT03157583) · Clinical Trials Directory